Market Outlook


  • Analyze the Analysts!  Monday, 15 Jul 2013 | 1:38 PM ET

    Jim Iuorio, TJM Institutional Services, takes a look at the latest analyst calls. Yelp was downgraded to neutral at UBS.

  • Inside Citi's earnings  Monday, 15 Jul 2013 | 1:14 PM ET

    Citigroup reported a 26 percent increase in profit, with CNBC's Simon Hobbs.

  • Gas prices fuel up  Monday, 15 Jul 2013 | 1:11 PM ET

    The AAA says the price of a gallon of gas in the U.S. is up $0.14 in a week, reports CNBC's Jane Wells.

  • Negative GDP ahead?  Monday, 15 Jul 2013 | 1:02 PM ET

    Will the markets face a negative GDP number in Q2? CNBC's Steve Liesman, offers insight; and Jack Ablin, BMO Private Bank; Jim Iuorio, TJM Institutional Services; and Simon Hobbs discuss.

  • FMHR Final Trade  Monday, 15 Jul 2013 | 12:59 PM ET

    The FMHR traders reveal their final trades of the hour.

  • European Markets Close Higher  Monday, 15 Jul 2013 | 11:31 AM ET

    CNBC's Simon Hobbs reports on all the market-moving events from Europe today.

  • Stocks little changed at open  Monday, 15 Jul 2013 | 10:09 AM ET

    Michael Cuggino, Permanent Portfolio Funds, and Brian Wesbury, First Trust Advisors, provide a preview of this week's market-moving news, including a slew of earnings and Bernanke's testimony on Capitol Hill.

  • Markets open for trading  Monday, 15 Jul 2013 | 9:30 AM ET

    The "Squawk on the Street" crew shares their thoughts on what investors should be watching throughout the trading day.

  • Monday's market roadmap  Monday, 15 Jul 2013 | 9:01 AM ET

    The "Squawk on the Street" news team reports on today's top business headlines, including Citi's earnings beat, AT&T's acquisition of Leap, and China's economic outlook.

  • Cramer's stocks to watch: Financials  Monday, 15 Jul 2013 | 8:53 AM ET

    Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell. Today, Cramer explains why he is keeping an eye on banks.

  • Technical check on the markets  Monday, 15 Jul 2013 | 8:41 AM ET

    Ryan Detrick, Schaeffer's Investment Research, checks the charts to get a technical read on whether the markets are giving bullish signals.

  • Decoding Bernanke  Monday, 15 Jul 2013 | 8:10 AM ET

    Austan Goolsbee, Chicago Booth School professor, discusses how long the Fed is likely to keep an accommodative position, the outlook on jobs and possible replacements for Bernanke.

  • Fuzzy numbers? Real China growth only half: Expert Monday, 15 Jul 2013 | 7:43 AM ET
    A shopper counts Chinese yuan banknotes as he shops for fruit and vegetables at a market in Shanghai, China.

    The official economic numbers that China released Monday are dramatically over-estimating growth there, the author of "The Coming Collapse of China" tells CNBC.

  • Bernanke & market's improved fundamentals  Monday, 15 Jul 2013 | 7:25 AM ET

    Joseph Tanious, JPMorgan Fund, discusses how the Fed's monetary policy has impacted the U.S. economy.

  • Dozens of earnings reports and two days of Fed testimony could make the coming week a tense time for bulls, who are hoping to see stocks keep breaking out to new highs.

  • Counting down to China GDP data  Friday, 12 Jul 2013 | 7:52 PM ET

    How might the Fed's monetary policy, and the GDP number out of China impact the markets? Kate Warne, Edward Jones, and Lee Munson, Portfolio Asset Management, discuss.

  • High-frequency trading is taking root on "K-Street." CNBC's Eamon Javers reports CoreSite operates this DC facility; and William Black, University of Missouri; Abigail Doolittle, The Seaport Group; and CNBC's Courtney Reagan, discuss whether high-frequency trading is ruining Wall Street.

  • Record breaking day for stocks  Friday, 12 Jul 2013 | 7:00 PM ET

    Does this market have legs? Abigail Doolittle, The Seaport Group; Steven Ricchuito, Mizuho Securities; and CNBC's Courtney Reagan, discuss.

  • No Huddle Offense: UPS data can't be ignored  Friday, 12 Jul 2013 | 6:58 PM ET

    Mad Money host Jim Cramer shares his final thoughts of the day.

  • Epizyme CEO: Cancer genome efforts being embraced  Friday, 12 Jul 2013 | 6:45 PM ET

    Epizyme is a fresh health care IPO on the market. Its CEO Robert Gould discusses his company's efforts to beat cancer